Skip to content
HowShorted

OptiNose, Inc. short interest in 2020

In 2020, OptiNose, Inc.'s disclosed short interest ran from 19.20% of shares outstanding on 15 Jan 2020 to 10.27% on 31 Dec 2020, a change of -8.93 percentage points. The year's high was 19.20% on 15 Jan 2020 and its low 10.27% on 31 Dec 2020, averaging 14.83% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 59.89 days on 14 Feb 2020. Full history: OptiNose, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for OptiNose, Inc. in 2020

2020 in figures

Start of year
19.20% (15 Jan 2020)
End of year
10.27% (31 Dec 2020)
Change
-8.93 pp
High
19.20% (15 Jan 2020)
Low
10.27% (31 Dec 2020)
Average
14.83%
Highest days to cover
59.89 (14 Feb 2020)
SEC filings marked
8

Every report in 2020

OptiNose, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202019.20%41.22
31 Jan 202019.16%53.65
14 Feb 202018.87%59.89
28 Feb 202018.65%39.04
13 Mar 202016.16%29.5410-K filed, results (8-K)
31 Mar 202014.93%19.24
15 Apr 202013.90%17.83
30 Apr 202013.19%20.16
15 May 202013.27%16.6010-Q filed, results (8-K)
29 May 202012.17%29.91
15 Jun 202012.71%23.36
30 Jun 202014.40%27.68
15 Jul 202015.45%7.39
31 Jul 202016.31%15.52
14 Aug 202014.44%18.5210-Q filed, results (8-K)
31 Aug 202016.62%14.50
15 Sep 202016.33%28.84
30 Sep 202015.07%15.56
15 Oct 202014.57%34.39
30 Oct 202013.10%19.25
13 Nov 202010.60%22.0510-Q filed, results (8-K)
30 Nov 202013.08%12.65
15 Dec 202013.44%19.13
31 Dec 202010.27%9.50

See also: OptiNose, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.